+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latin America Biochips Market 2019-2027

  • ID: 4772790
  • Report
  • Region: Latin America
  • 74 pages
  • Triton Market Research
1 of 4

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
Market Outlook

The author's report has determined the biochips market to proliferate at a compound annual growth rate of 13.77% during the forecast period 2019-2027.

Biochips market refers to the market of microelectronic-inspired devices that may contain millions of individual sensor embedded on a solid substrate. Biochips are used for diverse applications, including research in biotechnology such as proteomics and genomics, molecular diagnostics, and drug screening and development. They also provide other diagnostic applications such as microarray, microfluidic technologies, and biosensors.

Brazil, Mexico and countries forming the rest of Latin America together comprise the Latin America market for biochips.

Companies operating in the biotechnology domain are investing heavily into biochips. Private sector companies, too, have made funded various biotechnological research & development activities. These factors, along with the increased financing for drug delivery in the pharmaceutical sector, are expected to augment the growth of the biochips market in Latin America over the estimated years.

Technological breakthroughs in biotechnology are also expected to raise the demand for biochips in the market. Progression in technology and innovations in biochips and biosensors have led to numerous new applications of biomedical devices. Technological advancement in the digital microfluidics technology applications such as on-chip, automated drug discovery and biochips have been launched in the market.

However, lack of knowledge or proficiency regarding the use of biochip is a restraint to the market growth. In research and development, biochips are used by researchers with adequate knowledge to modify chips for collecting the necessary data for research purposes. Thus, before using biochips in diagnostic processes, it is essential for a person to be familiar with handling biochips so that he or she can operate chips without a lapse. Thus knowledge constraint is hindering the market growth of biochips.

Competitive Outlook

Biomerieux SA, Imgenex, Origene Technologies, Inc., Perkinelmer, Inc., Samsung Electronics, Inc., Cybrdi, Inc., Bio-Rad Laboratories, Inc., Gamida for Life Group, Cepheid, Inc., Agilent Technology, Inc., Biochain Institute, Inc., Thermo Fisher Scientific, Inc., Fluidigm Corporation, Merck GMBH and Illumina, Inc. are some of the prominent companies in the biochips market.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
1. Latin America Biochips Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.3. Evolution & Transition of Biochips
2.4. Porter's Five Force Analysis
2.5. Market Attractiveness Matrix
2.6. Industry Components
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Impact Analysis
2.10. Market Opportunity Insights
2.11. Industry Player Positioning
2.12. Key Market Strategies
2.13. Market Drivers
2.13.1. Growth in Personalized Medicines
2.13.2. Rising Incidences & Treatment of Cancer
2.13.3. Constant Rise in Healthcare Spending Worldwide
2.13.4. Increasing Number of Investments in Biotechnology R&D
2.14. Market Restraints
2.14.1. Inequalities in Healthcare Access
2.14.2. Inadequate Technical Awareness Related to Biochips
2.14.3. Complexity of Biological Systems
2.15. Market Opportunities
2.15.1. Developments in Biochips Technology
2.15.2. Asia Pacific to Offer Lucrative Growth Opportunities
2.15.3. Widening Application Areas of Biochips
2.16. Market Challenges
2.16.1. Availability of Substitute Technologies
2.16.2. Unclear Regulatory Guidelines
2.16.3. Cost Constraints

3. Latin America Biochips Market Outlook – By Type
3.1. Dna Chips
3.1.1. Agricultural Biotechnology
3.1.2. Cancer Diagnostics & Treatment
3.1.3. Drug Discovery
3.1.4. Gene Expression
3.1.5. Genomics
3.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
3.1.7. Other Dna Chips
3.2. Lab On a Chip
3.2.1. Clinical Diagnostics
3.2.2. Drug Discovery
3.2.3. Genomics
3.2.4. Point of Care & in Vitro Diagnosis
3.2.5. Proteomics
3.2.6. Other Lab On a Chip
3.3. Protein Chips
3.3.1. Diagnostics
3.3.2. Drug Discovery
3.3.3. Expression Profiling
3.3.4. High Throughput Screening
3.3.5. Proteomics
3.3.6. Other Protein Chips
3.4. Other Chips
3.4.1. Cell Arrays
3.4.2. Tissue Arrays

4. Latin America Biochips Market Outlook - By Substrate Material
4.1. Glass
4.2. Polymers
4.3. Silicon
4.4. Other Substrate Materials

5. Latin America Biochips Market Outlook - By End User
5.1. Biotechnology and Pharmaceutical Companies
5.2. Hospitals and Diagnostics Centers
5.3. Academic and Research Institute

6. Latin America Biochips Market - Regional Outlook
6.1. Brazil
6.2. Mexico
6.3. Rest of Latin America

7. Competitive Landscape
7.1. Agilent Technology Inc.
7.2. Biochain Institute Inc.
7.3. Biomerieux Sa
7.4. Bio-Rad Laboratories Inc.
7.5. Cepheid Inc.
7.6. Cybrdi Inc.
7.7. Fluidigm Corporation
7.8. Gamida For Life Group
7.9. Illumina Inc.
7.10. Imgenex
7.11. Merck Gmbh
7.12. Origene Technologies Inc.
7.13. Perkinelmer Inc.
7.14. Samsung Electronics Inc.
7.15. Thermo Fisher Scientific Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology
List of Tables
Table 1. Market Attractiveness Matrix For Biochips Market
Table 2. Vendor Scorecard of Biochips Market
Table 3. Regulatory Framework of Biochips Market
Table 4. Key Strategic Developments in Biochips Market
Table 5. Notable Investments Made in Biotechnology Industry in 2017
Table 6. Latin America Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 7. Latin America Biochips Market, By Type, 2019-2027 (In $ Million)
Table 8. Latin America Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 9. Latin America Biochips Market, By End User, 2019-2027 (In $ Million)
Table 10. Latin America Biochips Market, Country Outlook, 2019-2027 (In $ Million)

List of Figures
Figure 1. Latin America Biochips Market, 2019-2027 (In $ Million)
Figure 2. Porter's Five Force Analysis of Biochips Market
Figure 3. Key Impact Analysis
Figure 4. Timeline of Biochips
Figure 5. Market Opportunity Insights, By Type, 2018
Figure 6. Market Opportunity Insights, By End User, 2018
Figure 7. Industry Components of Biochips Market
Figure 8. Key Players Positioning in 2018 (%)
Figure 9. Worldwide Healthcare Spending, By Regions, 2014-2015 (% of Gdp)
Figure 10. Comparison of Healthcare Spending Per Capita and Out of the Pocket Health Expenditure
Figure 11. Latin America Biochips Market, By Dna Chips, 2019-2027 (In $ Million)
Figure 12. Latin America Dna Chips Market, By Agricultural Biotechnology, 2019-2027 (In $ Million)
Figure 13. Latin America Dna Chips Market, By Cancer Diagnostics & Treatment, 2019-2027 (In $ Million)
Figure 14. Latin America Dna Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 15. Latin America Dna Chips Market, By Gene Expression, 2019-2027 (In $ Million)
Figure 16. Latin America Dna Chips Market, By Genomics, 2019-2027 (In $ Million)
Figure 17. Latin America Dna Chips Market, By Single Nucleotide Polymorphism (Snp) Genotyping, 2019-2027 (In $ Million)
Figure 18. Latin America Dna Chips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 19. Latin America Biochips Market, By Lab On a Chip, 2019-2027 (In $ Million)
Figure 20. Latin America Lab On a Chip Market, By Clinical Diagnostics, 2019-2027 (In $ Million)
Figure 21. Latin America Lab On a Chip Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 22. Latin America Lab On a Chip Market, By Genomics, 2019-2027 (In $ Million)
Figure 23. Latin America Lab On a Chip Market, By Point of Care & in Vitro Diagnosis, 2019-2027 (In $ Million)
Figure 24. Latin America Lab On a Chip Market, By Proteomics, 2019-2027 (In $ Million)
Figure 25. Latin America Lab On a Chip Market, By Other Lab On a Chip, 2019-2027 (In $ Million)
Figure 26. Latin America Biochips Market, By Protein Chips, 2019-2027 (In $ Million)
Figure 27. Latin America Protein Chips Market, By Diagnostics, 2019-2027 (In $ Million)
Figure 28. Latin America Protein Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 29. Latin America Protein Chips Market, By Expression Profiling, 2019-2027 (In $ Million)
Figure 30. Latin America Protein Chips Market, By High Throughput Screening, 2019-2027 (In $ Million)
Figure 31. Latin America Protein Chips Market, By Proteomics, 2019-2027 (In $ Million)
Figure 32. Latin America Protein Chips Market, By Other Protein Chips, 2019-2027 (In $ Million)
Figure 33. Latin America Biochips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 34. Latin America Other Biochips Market, By Cell Arrays, 2019-2027 (In $ Million)
Figure 35. Latin America Other Biochips Market, By Tissue Arrays, 2019-2027 (In $ Million)
Figure 36. Latin America Biochips Market, By Glass, 2019-2027 (In $ Millions)
Figure 37. Latin America Biochips Market, By Polymers, 2019-2027 (In $ Millions)
Figure 38. Latin America Biochips Market, By Silicon, 2019-2027 (In $ Millions)
Figure 39. Latin America Biochips Market, By Other Substrate Materials, 2019-2027 (In $ Millions)
Figure 40. Latin America Biochips Market, By Biotechnology and Pharmaceutical Companies, 2019-2027 (In $ Millions)
Figure 41. Latin America Biochips Market, By Hospitals and Diagnostics Centers, 2019-2027 (In $ Millions)
Figure 42. Latin America Biochips Market, By Academic and Research Institute, 2019-2027 (In $ Millions)
Figure 43. Latin America Biochips Market, Regional Outlook, 2018 & 2027 (In %)
Figure 44. Brazil Biochips Market, 2019-2027 (In $ Million)
Figure 45. Mexico Biochips Market, 2019-2027 (In $ Million)
Figure 46. Rest of Latin America Biochips Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AGilent Technology Inc.
  • Biochain Institute Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Cybrdi Inc.
  • Fluidigm Corporation
  • Gamida For Life Group
  • Illumina Inc.
  • Imgenex
  • Merck GmbH
  • Origene Technologies Inc.
  • Perkinelmer Inc.
  • Samsung Electronics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4772790
Adroll
adroll